Publicaciones en colaboración con investigadores/as de Hospital de Galdakao - Usansolo (19)

2024

  1. Antibiotic stewardship programs in the Spanish emergency services: PROA-URG Study

    Revista Espanola de Quimioterapia, Vol. 37, Núm. 2, pp. 163-169

2023

  1. Increased let-7d-5p in non-alcoholic fatty liver promotes insulin resistance and is a potential blood biomarker for diagnosis

    Liver International, Vol. 43, Núm. 8, pp. 1714-1728

2022

  1. Implication of miR-155-5p and miR-143-3p in the Vascular Insulin Resistance and Instability of Human and Experimental Atherosclerotic Plaque

    International journal of molecular sciences, Vol. 23, Núm. 18

2021

  1. Concerted regulation of non-alcoholic fatty liver disease progression by microRNAs in apolipoprotein E-deficient mice

    DMM Disease Models and Mechanisms, Vol. 14, Núm. 12

2020

  1. Clinical validation of risk scoring systems to predict risk of delayed bleeding after EMR of large colorectal lesions

    Gastrointestinal Endoscopy, Vol. 91, Núm. 4, pp. 868-878.e3

2019

  1. Effectiveness and safety of the switch from remicade® to CT-P13 in patients with inflammatory bowel disease

    Journal of Crohn's and Colitis, Vol. 13, Núm. 11, pp. 1380-1386

2016

  1. High Body Mass Index as a Risk Factor for Hospitalization Due to Influenza: A Case-Control Study

    Archivos de Bronconeumologia, Vol. 52, Núm. 6, pp. 299-307

2015

  1. Spanish Rheumatology Society and Hospital Pharmacy Society Consensus on recommendations for biologics optimization in patients with rheumatoid arthritis, ankylosing spondylitis and psoriatic arthritis

    Rheumatology (United Kingdom), Vol. 54, Núm. 7, pp. 1200-1209

2014

  1. Endoscopic submucosal dissection

    Endoscopy, Vol. 46, Núm. 4, pp. 361-370

  2. Predictive factors of severe multilobar pneumonia and shock in patients with influenza

    Emergency Medicine Journal, Vol. 31, Núm. 4, pp. 301-307

2013

  1. Risk factors and effectiveness of preventive measures against influenza in the community

    Influenza and other Respiratory Viruses, Vol. 7, Núm. 2, pp. 177-183

2012

  1. Effectiveness of hand hygiene and provision of information in preventing influenza cases requiring hospitalization

    Preventive Medicine, Vol. 54, Núm. 6, pp. 434-439

  2. Prognosis of hospitalized patients with 2009 H1N1 influenza in Spain: Influence of neuraminidase inhibitors

    Journal of Antimicrobial Chemotherapy, Vol. 67, Núm. 7, pp. 1739-1745

  3. Score to identify the severity of adult patients with influenza A (H1N1) 2009 virus infection at hospital admission

    European Journal of Clinical Microbiology and Infectious Diseases, Vol. 31, Núm. 10, pp. 2693-2701

2007

  1. Caracteristicas psicométricas de la escala de satisfacción con el tratamiento antirretroviral (ESTAR): Estudio ARPAS (I)

    Farmacia Hospitalaria, Vol. 31, Núm. 6, pp. 331-339

  2. Evolution of the antimicrobial resistance of Pseudomonas aeruginosa in Spain: Second National Study (2003)

    Revista Espanola de Quimioterapia, Vol. 20, Núm. 2, pp. 222-229

  3. Preferencias, satisfacción y adherencia con el tratamiento antirretroviral: Estudio ARPAS (II)

    Farmacia Hospitalaria, Vol. 31, Núm. 6, pp. 340-352

2004

  1. Evaluación de un programa de atención farmacéutica dirigido a mejorar la adherencia al tratamiento antirretroviral

    Farmacia Hospitalaria, Vol. 28, Núm. 6 SUPPL. 1, pp. 19-26

2003

  1. Evolución de la resistencia antibiótica de Pseudomonas aeruginosa, Escherichia coli y Bacteroides fragilis (1997-2001)

    Revista Espanola de Quimioterapia, Vol. 16, Núm. 4, pp. 421-427